These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6796580)

  • 1. Purification and characterization of a cytosolic broad specificity beta-glucosidase from human liver.
    Daniels LB; Coyle PJ; Chiao YB; Glew RH; Labow RS
    J Biol Chem; 1981 Dec; 256(24):13004-13. PubMed ID: 6796580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sucrose gradient analysis of phospholipid-activated beta-glucosidase in type 1 and type 2 Gaucher's disease.
    Garrett KO; Prence EM; Glew RH
    Arch Biochem Biophys; 1985 Apr; 238(1):344-52. PubMed ID: 3920967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectors of three beta-glucosidases from human liver.
    Daniels LB; Gnarra JR; Glew RH
    Prog Clin Biol Res; 1982; 95():333-55. PubMed ID: 6812077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase.
    Daniels LB; Glew RH; Radin NS; Vunnam RR
    Clin Chim Acta; 1980 Sep; 106(2):155-63. PubMed ID: 6773704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.
    Glew RH; Daniels LB; Clark LS; Hoyer SW
    J Neuropathol Exp Neurol; 1982 Nov; 41(6):630-41. PubMed ID: 6813430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
    Basu A; Prence E; Garrett K; Glew RH; Ellingson JS
    Arch Biochem Biophys; 1985 Nov; 243(1):28-34. PubMed ID: 3933429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver.
    Owada M; Sakiyama T; Kitagawa T
    Pediatr Res; 1977 May; 11(5):641-6. PubMed ID: 870871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid beta-glucosidase and the diagnosis of Gaucher's disease in liver and spleen.
    Butterworth J; Broadhead DM
    Clin Chim Acta; 1978 Aug; 87(3):433-40. PubMed ID: 28186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain glucocerebrosidase in Gaucher's disease.
    Daniels LB; Coyle PJ; Glew RH; Radin NS; Labow RS
    Arch Neurol; 1982 Sep; 39(9):550-6. PubMed ID: 6810854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the activation of rat liver beta-glucosidase by sialosylgangliotetraosylceramide.
    Basu A; Glew RH
    J Biol Chem; 1985 Oct; 260(24):13067-73. PubMed ID: 3932339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The occurrence of two immunologically distinguishable beta-glucocerebrosidases in human spleen.
    Aerts JM; Donker-Koopman WE; van der Vliet MK; Jonsson LM; Ginns EI; Murray GJ; Barranger JA; Tager JM; Schram AW
    Eur J Biochem; 1985 Aug; 150(3):565-74. PubMed ID: 4018098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaucher's disease II. Studies on the kinetics of beta-glucosidase and the effects of sodium taurocholate in normal and Gaucher tissues.
    Choy FY; Davidson RG
    Pediatr Res; 1980 Jan; 14(1):54-9. PubMed ID: 6767218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Separation by electrofocusing of the molecular forms of splenic beta-glucosidase in normal subjects and Gaucher's disease].
    Maret A; Salvayre R; Nègre A; Douste-Blazy L
    Biomedicine; 1980 May; 33(3):82-6. PubMed ID: 6778520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.
    Basu A; Glew RH; Daniels LB; Clark LS
    J Biol Chem; 1984 Feb; 259(3):1714-9. PubMed ID: 6693432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2,3-di-O-tetradecyl-1-O-(beta-D-glucopyranosyl)-sn-glycerol is a substrate for human glucocerebrosidase.
    Glew RH; Gopalan V; Hubbell CA; Devraj RV; Lawson RA; Diven WF; Mannock DA
    Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):557-63. PubMed ID: 1900989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enzymatic hydrolysis of 6-acylamino-4-methylumbelliferyl-beta-D-glucosides: identification of a novel human acid beta-glucosidase.
    Mikhaylova M; Wiederschain G; Mikhaylov V; Aerts JM
    Biochim Biophys Acta; 1996 Oct; 1317(1):71-9. PubMed ID: 8876629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis of Gaucher's disease in liver using 4-methylumbelliferyl-beta-D-glucopyranoside.
    Broadhead DM; Butterworth J
    Clin Chim Acta; 1977 Feb; 75(1):155-61. PubMed ID: 14796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Glucosidase activities in the Norrbotten type of juvenile Gaucher's disease.
    Hultberg B
    Acta Neurol Scand; 1978 Aug; 58(2):89-94. PubMed ID: 30251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaucher's disease.
    Patel AL; Shaikh WA; Khobragade AK; Soni HG; Joshi AS; Sahasrabudhe GS; Chole PV
    J Assoc Physicians India; 2009 May; 57():410-1. PubMed ID: 19634291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple forms of membrane-bound beta-glucosidase in Gaucher's disease.
    Yaqoob M; Carroll M
    Clin Genet; 1981 Aug; 20(2):161-7. PubMed ID: 6796311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.